We aimed to investigate whether timing of SGLT‐2 is before the index diagnosis of HF, and second, adherence to SGLT‐2is in the form of the proportion of days covered metric matter in patients with HF and diabetes. This evidence concerns the gene SLC5A2 and hydrops fetalis.